KKT LLC invested just over JP¥100 million in Bioworks Co., Ltd. Bioworks develops the plant-derived next-generation synthetic fiber PlaX. KKT acquired 21 ordinary shares through a third-party allocation.
Investment terms
KKT paid JP¥4.8 million per share. The share purchase closed on October 23, 2026. Bioworks will direct the funds to development, patent-related work, staffing, outsourcing, and working capital.
Company context
Bioworks was founded in October 2015. It is based in Seika, Kyoto Prefecture, with an office in Tokyo. The company develops, manufactures, and sells modified polylactic acid compound and PlaX products.
What PlaX does
PlaX uses polylactic acid made from plant sources such as sugarcane. Bioworks adds its own plant-derived additives to improve physical properties and dyeability. The material can be supplied as long or short fibers for apparel, outdoor gear, household goods, and industrial materials.
KKT plans to provide more than capital. It will share its business networks and development expertise. The two companies will explore applications in sports uniforms, hospitality fabrics, and regional collaborations.